Vyvanse vs Adderall: Which Is More Addictive?

Vyvanse and Adderall can both be addictive, and both carry the same FDA boxed warning about misuse, abuse and addiction. Vyvanse's prodrug design gives it a somewhat lower abuse potential at typical doses, because the body has to convert it slowly into active amphetamine. But that advantage shrinks at high doses, and people do become addicted to Vyvanse, so neither drug is "safe" from addiction.

This guide compares how the two medicines work, what the FDA labels say about abuse potential, which patterns of misuse are more common with each, and what matters more than the brand name when it comes to addiction risk.

How Vyvanse and Adderall Differ

Both medicines are amphetamine-based stimulants used for ADHD. The key difference is how the active drug reaches the brain.

Adderall is a mix of amphetamine salts. The active drug is in the pill, ready to be absorbed. The immediate-release tablet reaches its peak level about three hours after a dose, according to its label, and it is also sold as an extended-release capsule (Adderall XR).

Vyvanse (lisdexamfetamine) is a prodrug. On its own it is inactive. The Vyvanse label explains that red blood cells split it into dextroamphetamine and an amino acid, l-lysine. This step happens mostly in the blood and sets the pace for how fast active amphetamine builds up. In adults, the label reports dextroamphetamine peaking roughly four hours after a capsule, and the parent drug is generally undetectable by eight hours.

What the FDA Labels Say About Abuse Potential

The Vyvanse label includes an abuse-liability study in adults with a history of drug abuse. Each person took single doses of different drugs and rated how much they liked the effect. At 100 mg, Vyvanse produced significantly lower "drug liking" scores than 40 mg of immediate-release dextroamphetamine. At 150 mg, though, the liking scores were similar to that dextroamphetamine dose.

The label also describes an injection study. Lisdexamfetamine given into a vein still produced positive effects greater than a placebo, but weaker than an equal amount of injected dextroamphetamine. Because conversion happens in the blood, changing the route does not skip that step, which is part of why Vyvanse delivers a less sudden high than drugs that are active right away.

The Adderall label has no comparable study. Instead, it carries the class-wide warning that applies to all prescription stimulants: a high potential for abuse and misuse that can lead to a substance use disorder, including addiction, with overdose and death possible. Both labels say the danger is greater with higher doses and with methods like snorting or injecting.

So Which Is More Addictive?

Based on the label evidence, immediate-release Adderall is likely easier to misuse for a quick high than Vyvanse. The effect comes on faster, and tablets are simple to take in extra doses through the day. Vyvanse's slower conversion blunts that rush at ordinary doses.

But "less appealing to misuse" is not the same as "not addictive." Three points matter:

• The ceiling is real but limited. The 150 mg results show that high enough doses of Vyvanse produce a liking effect similar to dextroamphetamine.
• Both cause tolerance and dependence. Each label says repeated use can lead to tolerance and that stopping suddenly after long use can bring a crash with low mood and fatigue.
• Both have the same federal schedule. Both labels list the drug as a Schedule II controlled substance, the strictest category for drugs with an accepted medical use.

In practice, people misusing Vyvanse often take far more than prescribed to feel something, or stack doses through the day. For a closer look at each drug, see Is Vyvanse addictive? and Is Adderall addictive?

Why Prescribers Sometimes Choose Long-Acting Stimulants

SAMHSA's TIP 33 lists long-acting formulations among the steps prescribers can use to reduce diversion, along with medication agreements, smaller quantities and pill counts. The ASAM and AAAP guideline on stimulant use disorder also suggests considering extended-release formulations when a person with a stimulant use disorder also needs ADHD treatment. Vyvanse and Adderall XR both fall in this long-acting group.

That does not mean switching from Adderall to Vyvanse is a cure for misuse. A person who has been crushing, snorting or binging on Adderall needs a full assessment, not only a new prescription. The same guideline recommends that anyone misusing prescription stimulants be evaluated for ADHD, and that the treatment plan weigh stimulant, nonstimulant and behavioral options.

What Matters More Than the Brand

Addiction risk depends more on how the drug is used than on which drug it is. Warning signs are the same for both:

• Taking more than prescribed or more often
• Using someone else's pills or buying them
• Snorting, injecting or opening capsules
• Running out early or seeing several prescribers
• Needing higher doses for the same effect
• Crashes of exhaustion and low mood between doses

The FDA notes that most people who misuse stimulants get them from friends or family, so safe storage and never sharing pills matter with either drug. It also warns that pills sold illegally may contain fentanyl or methamphetamine, and that mixing stimulants with alcohol, or with opioids not prescribed to you, can be deadly. Our guide to the signs of Adderall addiction applies closely to Vyvanse as well.

Stopping and Getting Help

If you take either medicine and want to stop, talk to your prescriber first rather than quitting suddenly after long or heavy use. Our guides on how to taper off Vyvanse and how to taper off Adderall explain what that usually involves. If low mood turns into thoughts of suicide, call or text 988. Call 911 for chest pain, seizures, confusion or very high body temperature.

Treatment is the same for both drugs. There is no FDA-approved medication for stimulant use disorder; SAMHSA and NIDA point to contingency management and cognitive behavioral therapy as the best-supported approaches. Read how stimulant addiction is treated for more.

To find a program, use the stimulant rehab directory or the Adderall rehab directory. You can browse by state, such as stimulant rehab in North Carolina, or by city, such as stimulant rehab in Phoenix. More detail on each drug is in our Vyvanse addiction guide and Adderall addiction guide.

Sources

• Vyvanse Prescribing Information (U.S. Food and Drug Administration)
• Adderall Prescribing Information (U.S. Food and Drug Administration)
• FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions (U.S. Food and Drug Administration)
• TIP 33: Treatment for Stimulant Use Disorders (SAMHSA)
• The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (PubMed Central, National Library of Medicine)
• Misuse of Prescription Drugs Research Report (National Institute on Drug Abuse)

Related guides

• Adderall Addiction: Signs, Risks and Treatment Options
• Vyvanse Addiction: Signs, Risks and Treatment Options
• Ritalin and Concerta Addiction: Signs, Risks and Treatment
• Gabapentin Addiction: Misuse, Risks and Treatment Options
• Lyrica (Pregabalin) Addiction: Risks and Treatment Options
• Soma and Muscle Relaxer Addiction: Risks and Treatment

Find treatment

Stimulant Rehab by stateAdderall Rehab by state